21 Grants
2006
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA092403-04S1), $45,721USD, 04/08/2003 -- 03/31/2008
 
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA092403-04), $293,316USD, 04/08/2003 -- 03/31/2008
2005
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA092403-03S1), $44,672USD, 04/08/2003 -- 03/31/2007
 
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA092403-03), $300,375USD, 04/08/2003 -- 03/31/2007
2004
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA092403-02S1), $29,594USD, 04/08/2003 -- 03/31/2007
 
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA092403-02), $292,143USD, 04/08/2003 -- 03/31/2007
2003
PET Radiotracers to Evaluate Tumor Multidrug Resistance
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA092403-01A2), $287,025USD, 04/08/2003 -- 03/31/2007
 
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA070845-07), $363,578USD, 06/15/1996 -- 02/28/2005
2002
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA070845-06), $352,988USD, 06/15/1996 -- 02/29/2004
2001
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA070845-05), $365,630USD, 06/15/1996 -- 02/29/2004
2000
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA070845-04A1), $332,723USD, 06/15/1996 -- 02/29/2004
1998
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA070845-03), 06/15/1996 -- 02/29/2000
1997
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA070845-02), 06/15/1996 -- 05/31/1999
1996
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA070845-01), 06/15/1996 -- 05/31/1999
1993
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA046909-08), 08/01/1987 -- 06/30/1995
1992
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA046909-07), 08/01/1987 -- 05/31/1994
1991
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA046909-06), 08/01/1987 -- 05/31/1994
1990
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA046909-05), 08/01/1987 -- 05/31/1994
1989
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA046909-04), 08/01/1987 -- 05/31/1990
1988
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA046909-03), 08/01/1987 -- 05/31/1990
1987
RADIOPHARMACEUTICALS LABELED WITH METAL RADIONUCLIDES
GREEN, MARK A
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA046909-02), 08/01/1987 -- 05/31/1990